Fresenius Medical Care AG (FMS) EBIAT (2009 - 2025)

Fresenius Medical Care AG (FMS) has 17 years of EBIAT data on file, last reported at $1.1 million in Q4 2025.

• In Q4 2025, EBIAT rose 98.13% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $1.5 billion (up 127.93% YoY), while the FY2025 annual figure was $1.4 billion, up 75.09% from the prior year.
• EBIAT retreated to $1.1 million in Q4 2025, from $382.7 million in the prior quarter.
• Across five years, EBIAT topped out at $854.1 million in Q1 2025 and bottomed at $536890.8 in Q4 2023.
• A 5-year average of $225.9 million and a median of $216.1 million in 2022 frame the typical range for EBIAT.
• Annual changes were most pronounced in 2022 — EBIAT tumbled 51.95% — and 2025, when it soared 566.3%.
• Year by year, EBIAT stood at $1.1 million in 2021, then tumbled by 38.04% to $687039.7 in 2022, then dropped by 21.85% to $536890.8 in 2023, then increased by 7.06% to $574811.4 in 2024, then soared by 98.13% to $1.1 million in 2025.
• The last three EBIAT figures came in at $1.1 million (Q4 2025), $382.7 million (Q3 2025), and $307.9 million (Q2 2025), per Business Quant data.

Peer Comparison